Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously Iain C Macdougall, R David Hutton, Ivor Cavill, Gerald A Coles, John D Williams Recombinant human erythropoietin is being used increasingly to treat renal anaemia in patients receiving haemodialysis and continuous ambulatory peritoneal dialysis. Its efficacy is undisputed; nevertheless, several centres have reported that some patients have responded poorly, slowly, or not at all. We report on five patients who responded poorly to such treatment until they were given iron intravenously.
Case reports
The five patients we describe participated in a study assessing the effect of erythropoietin on renal anaemia in 11 patients who were receiving regular haemodialysis. All five were treated with erythropoietin (Boehringer Mannheim) 240 U/kg/week intravenously and started prophylactic oral iron supplementation (ferrous gluconate 300 mg/day; 35 mg elemental iron) two weeks before the treatment with erythropoietin. Each patient had a normal serum ferritin concentration before treatment (51, 40, 44, 34, and 37 tDuring four weeks after treatment with iron was started.
SAfter four weeks of treatment with iron.
,ug/l and transferrin saturations >30% before treatment). Each of the five patients had an initial rise in haemoglobin concentration, which was not sustained; they were then given iron dextran intravenously (Imferon; 50 mg elemental iron/ml) 1 ml twice weekly during the last hour of dialysis. The mean weekly rise in haemoglobin concentration during the four weeks before intravenous treatment with iron was 2-0 g/l; this rose to 5 3 g/l after the treatment was started (p<0005, paired t test), indicating more effective erythropoiesis even though the dose of erythropoietin was the same (table) . Four of the patients had normal serum ferritin concentrations immediately before treatment with iron, suggesting adequate stores of iron in marrow; the remaining patient had a concentration at the lower limit of the normal range. In contrast, all five patients had low transferrin saturations (<20%).
Comment
Our data show a retarded response of haemoglobin concentration to erythropoietin, which was corrected by giving iron intravenously. Eschbach et al also reported on a patient in whom the response of the packed cell volume declined in the presence of an ample serum ferritin concentration (518 [tg/l) but low transferrin saturation (13%); this patient also responded to intravenous treatment with iron dextran.' Erythropoietin seems to stimulate erythropoiesis to such an extent that the demand for iron can exceed the body's ability to release it from stores. This may lead to a functional iron deficiency, which can occur when serum ferritin concentrations are normal and iron can be detected in the marrow by staining.
Previous studies have suggested that stores of iron are adequate for erythropoiesis only if for every 50 g/l rise in haemoglobin concentration a serum ferritin concentration of ¢ 100 jig/l is present.2 Patients who are particularly likely to develop functional iron deficiency, therefore, are those with serum ferritin BMJ VOLUME 299 concentrations <100 [tg/l before treatment with erythropoietin.
Transferrin saturation is a good indicator of the current balance of supply and demand of plasma iron, although it is an inadequate indicator of the amount of iron stored. In addition, Bainton and Finch showed that once the transferrin saturation falls below 16% iron supply for erythropoiesis may be inadequate.4 Our data also suggest that, during treatment with erythropoietin, monitoring of transferrin saturation is more reliable for detecting functional iron deficiency than is monitoring of serum ferritin concentration.
We believe that functional iron deficiency will become an increasing problem as treatment with erythropoietin is used more widely unless prophylactic iron is given parenterally when indicated-that is, when transferrin saturation falls below 20%. This iron supplementation should also optimise the cost effectiveness of the drug. We determined whether compliance would improve if a letter of invitation contained a definite appointment for screening rather than an open ended request to make an appointment.
Subjects, methods, and results
A sample of 450 women aged 45-64 was identified from the age-sex registers of two general practitioners from one practice in Aylesbury and randomly allocated to receive either a letter with an appointment (group 1) or an open ended letter of invitation (group 2) for breast cancer screening. The letters were signed by the general practitioner and had, as far as possible, identical texts. At the screening office alternate appointments were allocated to the two groups.
Women in group 1 were asked to contact the screening service to cancel or alter appointments but not to confirm them. Women in group 2 were invited to return a form indicating convenient times; an appointment was then sent. Non-responders were sent a reminder after three weeks. Non-attenders from both groups were sent another appointment.
Both groups were comparable for age, previous screening (56 (30%) and 69 (34%) respectively had been screened before as volunteers), and where they lived.
Three invitations were accidentally sent to men. These and women who had moved, were duplicated on the register, and were known to have been screened recently were excluded. Nine women were inadvertently sent invitations instead of appointments, and one was sent an appointment instead of an invitation; they were also excluded. This left 188 women in group 1 and 204 women in group 2.
The From a total of 273 appointments issued to women in group 1, 45 (24%) were unused through non-attendance; 32 (17%) became available for reuse-15 (80%) after cancellation and 17 (90%) after refusal or when letters were returned unopened. Unfilled and cancelled appointments in group 2 each accounted for under 2% (4) of the total.
Comment
This study shows that including an appointment in the invitation significantly enhances compliance with screening compared with an open ended invitation, confirming earlier findings reported for cervical screening.5 The improvement persisted across all contacts and age bands and remained regardless of screening history. This improvement may have arisen because a definite appointment may place more onus on women to attend.
The postage for group 1 cost about half that for group 2. Also, clerical staff reported that they found the appointment strategy more straightforward than the invitation strategy, though the work entailed was different. Non-responders are never given appointments with a system of open ended invitations. With pre-allocated appointments several remain vacant unless overbooking is allowed. Overbooking of preallocated appointments, however, remains to be tried,
